Multiple myeloma is a type of blood cancer that affects plasma cells. In multiple myeloma, malignant plasma cells accumulate in the bone marrow (the soft, spongy tissue at the center of your bones), crowding out the normal plasma cells that help fight infection. These malignant plasma cells then produce an abnormal antibody called M protein, which offers no benefit to the body and may cause tumors, kidney damage, bone destruction, and impaired immune function. The hallmark characteristic of multiple myeloma is a high level of M protein in the blood.
Multiple myeloma typically displays the most activity in bone marrow, which includes the marrow in the spine, pelvic bones, ribs, shoulders, and hips. Though it is rarely curable, multiple myeloma is a highly manageable disease that has seen rapid medical advancement over the past decade. With the creation of the Multiple Myeloma Research Foundation (MMRF) and the push for advancement of multiple myeloma therapies, ten new drugs have been approved in the time it typically takes to obtain a single drug approval. The MMRF continues to investigate and fund the most promising treatments for multiple myeloma. More information can be found atwww.themmrf.org.
Fight back and help fund research with our durable punching pad sock. The sock features an image of multiple myeloma cancer cells, which you can punch out of existence.
$2 of each sale will go to the Multiple Myeloma Research Foundation (MMRF).